Trial Condition(s):
Contraception
To evaluate compliance to treatment regimen (rate of deviations from the prescribed regimen) in Polish females treated with different low dose oral contraceptives (DOC)
Bayer Identifier:
14340
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Trial Purpose
Adherence to the dosing scheme is the principal element of Combined Oral Contraceptives efficiency. On the other hand noncompliance seemed to be an inseparable element of any oral treatment. The aim of the study is to evaluate in everyday practice the relation between dosage errors and indicated factors, potentially influencing the compliance with the dosing scheme.
Inclusion Criteria
- Patients at the age of over 18 requiring contraception. The decisions would be made at the discretion of the attending physician.
Exclusion Criteria
- According to official Summary of Product Characteristics (SmPC) contraindications.
Trial Summary
Enrollment Goal
Trial Dates
Phase
Could I receive a placebo?
Products
Accepts Healthy Volunteers
Where to Participate
| Locations | |
|---|---|
Locations Investigative Site Many Locations, Poland | Contact Us: E-mail: [email protected] Phone: Not Available |
Trial Design
Prospective, open-label observational survey evaluating patients compliance to administration regimen during low dose combined oral contraceptive use in everyday praxis Data on Oral Contraceptives Compliance - DOC study
Trial Type:
Observational
Intervention Type:
Drug
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1
Primary Outcome
- The percentage of users showing noncompliant behaviorsTimeframe: 3 consecutive cycles
Secondary Outcome
- The characteristics of noncompliant behaviorTimeframe: 3 consecutive cycles
- The relation between noncompliant behavior and selected factorsTimeframe: 3 consecutive cycles
Additional Information
Copyright © Bayer
Powered by
